Reduction-responsive RNAi nanoplatform for enhanced cancer sonoimmunotherapy via dual inhibition of mitophagy and Nrf2 pathways
Open Access
- 11 July 2025
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (16) , 7973-7989
Abstract
Rationale: Sonodynamic therapy (SDT) has emerged as a promising non-invasive modality with deeper tissue penetration than photodynamic or chemodynamic therapies. However, its therapeutic efficacy remains limited due to inadequate reactive oxygen species (ROS) generation, largely attributed to tumor-intrinsic antioxidant systems and mitophagy. Existing combinations of SDT with immunotherapy are primarily additive and fail to address the mechanistic interplay between ROS suppression and immune evasion.Keywords
This publication has 39 references indexed in Scilit:
- Nanostructure Engineering by Simple Tuning of Lipid CombinationsAngewandte Chemie International Edition, 2020
- Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapyBiomaterials, 2019
- NRF2 and the Hallmarks of CancerCancer Cell, 2018
- Nrf2-Keap1 signaling in oxidative and reductive stressBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018
- Monitoring and Measuring AutophagyInternational Journal of Molecular Sciences, 2017
- Oxidative stress and autophagy: the clash between damage and metabolic needsCell Death & Differentiation, 2014
- Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor.2010
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential AlternativesAngewandte Chemie International Edition, 2010
- Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery PlatformACS Nano, 2008
- Structural Basis for Sorting Mechanism of p62 in Selective AutophagyJournal of Biological Chemistry, 2008